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P U B L I S H E D B Y E L S E V I E R I N C .LettersGlobal Survey of
Esophageal and
Gastric Injury in Atrial
Fibrillation Ablation
Incidence, Time to Presentation,
and OutcomesCatheter ablation of the left atrial (LA) posterior wall
may result in esophageal injury ranging from mild
erythema to ulceration and, in rare but devastating
cases, esophageal perforation or ﬁstula (1). In addi-
tion, vagus nerve damage can result in gastric hypo-
motility and gastroparesis (2). There are limited data
regarding the incidence and outcomes of these
complications.
We circulated an online survey to the 3080 regis-
tered physician members of the Heart Rhythm
Society, as well as all physicians who perform atrial
ﬁbrillation (AF) ablation. We collected responses
between November 1, 2013 and June 1, 2014. Of the
3080 physicians who received the survey, 405
responded (13%). In aggregate, 191,215 AF abla-
tions were performed by responding physicians, and
esophageal perforation or ﬁstula was reported in 31
patients (0.016%) by responding physicians 30 (7%).
Gastroparesis was reported in 63 patients by 47
physicians. The mean postoperative day (POD) of
diagnosis was 5.7  5.8 days, and gastroparesis
symptoms resolved completely in 59 patients (94%).
Patients in whom gastroparesis did not completely
resolve received the diagnosis at a signiﬁcantly
later POD compared with patients whose symptoms
resolved completely (15.3  6.2 vs. 5.0  5.2;
p < 0.001) (Figure 1).
Esophageal ulcer was reported in 51 patients, of
whom 37 (73%) had complete resolution of ulcer
symptoms. Patients whose esophageal ulcer symp-
toms did not completely resolve received the diag-
nosis at a signiﬁcantly later POD than patients with
complete symptom resolution (16.2  4.3 vs. 2.9  3.1;
p < 0.001) (Figure 1).
Symptom onset for esophageal perforation or
ﬁstula was reported on POD 19.3  12.6 (range,6 to 59 days) (Figure 1). Of the 28 patients with
esophageal perforation or ﬁstula for whom detailed
information was provided, 20 (71%) had an
atrial-esophageal ﬁstula (AEF), 4 (14%) a pericardial-
esophageal ﬁstula, and 4 (14%) esophageal perfora-
tion without ﬁstula formation. Of these 28 patients,
a signiﬁcantly greater proportion of those who died
or had severe neurological injury ultimately received
a diagnosis of AEF (94% vs. 36%; p ¼ 0.002). All
patients with AEF who survived without severe
neurological injury underwent thoracic surgery. Two
patients (7%) in whom an AEF developed died after
AF ablation with a second-generation cryoballoon
procedure.
The present survey—the largest dataset of
gastroesophageal injury in AF ablation to date—
demonstrates that gastroparesis, esophageal ulcer,
and esophageal perforation occur in a bimodal
temporal distribution of injury; spontaneously
resolving injury presents primarily in the ﬁrst
several days post-ablation, and more severe injury
primarily after 10 days. Proposed mechanisms for
esophageal injury include direct thermal injury,
which may account for early symptoms, and
ischemic injury, which may account for later, more
severe injury (3).
In a previous global survey of complications
related to AF ablation performed from 2003 to 2006,
Cappato et al. (4) reported a 0.04% rate of AEF. In a
national survey performed from 2004 to 2005 by
Ghia et al. (5), AEF occurred in 0.03% of patients in a
cohort of 20,425. The incidence of esophageal
perforation without ﬁstula formation and pericardial-
esophageal ﬁstula was not reported in either previous
survey. The 0.016% incidence of esophageal perfora-
tion and 0.011% incidence of AEF in the present
study are both signiﬁcantly lower (p < 0.001) than the
incidence of AEF reported in the previous surveys,
and the total number of AF ablations performed by
survey physicians is greater than in previous studies,
suggesting that the risk of esophageal perforation
with AF ablation may now be lower than previously
reported.
Self-selection bias is a limitation of survey-based
data. Physicians retrospectively reported all data,
and inaccurate responses due to poor recall were not
excluded. Given the observational nature of the
FIGURE 1 Time Course of Gastroesophageal Injury After Atrial Fibrillation Ablation
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(A) Time course of gastroparesis diagnosis stratiﬁed by patients with spontaneous
resolution of symptoms (n ¼ 59, red) and patients whose symptoms remain unresolved
(n ¼ 4, blue). (B) Time course of esophageal injury diagnosis stratiﬁed by patients with
spontaneous resolution of ulcer symptoms (n ¼ 37, red), patients whose ulcer symptoms
did not resolve spontaneously but did not have esophageal perforation (n ¼ 14, blue),
and patients in whom esophageal perforation developed (n ¼ 31, green).
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1378study, it is impossible to determine causation versus
correlation.
We observed a bimodal temporal distribution of
gastroesophageal injury after AF ablation, and all
gastroparesis and esophageal injury diagnosed in the
ﬁrst 5 days after ablation resolved spontaneously.
Symptom onset of gastric and esophageal injury more
than 5 days after AF ablation is concerning for moresevere injury. Our data reinforce the importance of
close postoperative follow-up after AF ablation, even
if patients do not report symptoms in the ﬁrst few
days after ablation of the posterior LA wall.*Chirag R. Barbhaiya, MD
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Remodeling Response in
Exercise-Resistant RatsIncreasing a subject’s aerobic exercise capacity with
training decreases cardiovascular morbidity and mor-
tality. Of major concern is the key observation that
